{
  "paper_metadata": {
    "pmid": "39455978",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted genetic variant information specifically for the BRCA2 gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.332379755CTGAG",
      "protein_notation": "p.S2988fs",
      "genomic_position": "chr13:332379755",
      "clinical_significance": "Pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Not specified",
        "phenotype": "Prostate cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 1,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 50.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "Prostate cancer",
          "evidence_sentence": "Among these patients, four men (3.6%) carried a germline DDR PTV, including BRCA2 (n=2)..."
        }
      ],
      "functional_data": {
        "summary": "The variant is a protein-truncating variant (PTV) associated with prostate cancer.",
        "assays": []
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "Strong evidence based on clinical significance",
      "source_location": "Table 1, Row 1",
      "additional_notes": "This variant is one of two BRCA2 mutations identified in the study.",
      "key_quotes": [
        "We also identified two BRCA2 mutations...",
        "Among these patients, four men (3.6%) carried a germline DDR PTV, including BRCA2 (n=2)..."
      ]
    },
    {
      "gene_symbol": "BRCA2",
      "cdna_notation": "c.33232496G>T",
      "protein_notation": "p.E340*",
      "genomic_position": "chr13:33232496",
      "clinical_significance": "Pathogenic",
      "patients": {
        "count": 1,
        "demographics": "Not specified",
        "phenotype": "Prostate cancer"
      },
      "penetrance_data": {
        "total_carriers_observed": 2,
        "affected_count": 1,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 50.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "Case_2",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "affected",
          "phenotype_details": "Prostate cancer",
          "evidence_sentence": "Among these patients, four men (3.6%) carried a germline DDR PTV, including BRCA2 (n=2)..."
        }
      ],
      "functional_data": {
        "summary": "The variant is a protein-truncating variant (PTV) associated with prostate cancer.",
        "assays": []
      },
      "segregation_data": "Not specified",
      "population_frequency": "Not specified",
      "evidence_level": "Strong evidence based on clinical significance",
      "source_location": "Table 1, Row 2",
      "additional_notes": "This variant is one of two BRCA2 mutations identified in the study.",
      "key_quotes": [
        "We also identified two BRCA2 mutations...",
        "Among these patients, four men (3.6%) carried a germline DDR PTV, including BRCA2 (n=2)..."
      ]
    }
  ],
  "tables_processed": [
    {
      "table_name": "Table 1",
      "table_caption": "List of DNA repair germline mutations annotated by different methods",
      "variants_extracted": 2
    }
  ],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data for BRCA2 variants were successfully extracted."
  }
}